2003;2, CD001939
In recent years, interest in GLP-1 receptor agonists has surged, driven by their dual benefits in glycemic control and weight loss among individuals with DM2 and other metabolic conditions [23]
Researchers study these effects for body disorder uses
WHO endorsement sparks new discussion around GLP-1 drugs and PCOS Videos WHO endorsement sparks new discussion around GLP-1 drugs and PCOS02:32 | December 14, 2025 Calls for more ovarian cancer treatment options02:21 | July 23, 2026 Maritime provinces facing health-care strain, looking to feds for financing02:13 | July 22, 2026 Funding boost for project to improve mental health services for youth in N.S.02:07 | July 21, 2026 Upwards of 12-hour waits for ER departments in Nova Scotia02:19 | July 16, 2026 New highly potent drug found amid overdose concerns in Maritimes02:18 | July 14, 2026 North End Community Health Centre Releases New Impact Report05:31 | July 14, 2026 Run With Rob Returns with His Biggest Challenge Yet05:52 | July 13, 2026 Importance of support and social services for home caregivers02:15 | July 9, 2026 Last One Standing & Summer Bash: Local Athletes Unite to Fight Brain Cancer05:41 | July 9, 2026 Virtual care promising quicker access amid health care challenges for Maritimers02:15 | July 3, 2026 Beach safety with Nova Scotia Lifeguard Service05:49 | July 3, 2026 How Maritimers are dealing with the scorching temperatures amid heat warning01:59 | July 2, 2026 Health Matters: ON, QC heat wave spreads to the Maritimes02:21 | July 2, 2026 Nova Scotian family raises money for rare genetic condition clinical trial02:21 | June 28, 2026 NS Accessibility Association launches new pilot in a unique way05:42 | June 25, 2026 Nova Scotia man turns speed walking into way to give back02:12 | June 22, 2026 Researchers raise concerns around social media bans02:09 | June 10, 2026 Paddling for a purpose: national campaign raises money for autism supports05:31 | June 10, 2026 African Nova Scotian advocates want expansion for community health program02:05 | June 9, 2026 Famillies relieved after tentative deal reached in striking LTC workers01:55 | June 8, 2026 New equine therapy program to help Nova Scotians with addictions recovery02:10 | June 7, 2026 Halifax-area man with MS speaks out about lack of accessibility02:15 | June 4, 2026 NS patients spread awareness of Spinal CSF Leaks02:12 | June 3, 2026 RBC Training Ground stops in Halifax01:55 | May 31, 2026 Family and community power Fredericton MS Walk01:50 | May 31, 2026 Nova Scotians challenging stigma of borderline personality disorder02:54 | May 30, 2026 Nova Scotia sexual assault survivor finds strength in being seen and heard02:56 | May 26, 2026 First responders, community feeling impact of newborn death in Halifax02:15 | May 26, 2026 Brianna Voss to Walk 200 Kilometres Across Nova Scotia for Huntington Disease Awareness and Support05:48 | May 26, 2026 MDC Walk & Roll champions Danny & Michelle Morris05:29 | May 26, 2026 Hundreds rally in N.S
In Australia, where semaglutide 0.5 mg and 1 mg is approved and subsidised for the treatment of type-2 diabetes, the Therapeutic Goods Administration (TGA) warned in May that off-label prescribing of the drug to people with obesity had caused a supply shortage
